This phenomenon involves the transcriptional silencing of tumor suppressor genes (including BRCA1/BRCA2, TP53BP1, SMAD4) and the abnormal activation of oncogenes (such as PDGFRA, PIK3CA, and BRAF), thereby facilitating tumor initiation and progression. This evidence concerns the gene PDGFRA and neoplasm.